BOSTON THERAPEUTIC USD0.001 (BTHE)

0.07
OTC Markets
Prev Close 0.07
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.04 / 0.17
Exchange OTC Markets
Shares Outstanding 47.76B
Market Cap 3.34M
Div & Yield N.A. (N.A)

BOSTON THERAPEUTICS Reports Data From The POC Asia Trial At The American Diabetes Association's 77th Scientific Sessions

A Study to Evaluate the Effect of BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycemia in High Risk Chinese Subjects with Pre-Diabetes

SeeThruEquity Issues Quarterly Update On Boston Therapeutics

SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a quarterly update on Boston...

[video] New Tablet From Boston Therapeutics Reduces Sugar Intake for Diabetics

Boston Therapeutics new PAZ320 tablet is designed to reduce a person's sugar intake before eating a meal.

Boston Therapeutics' New Tablet Reduces Sugar Intake for Diabetics

Boston Therapeutics new PAZ320 tablet is designed to reduce a person's sugar intake before eating a meal.